ArticleNeurosciences (Riyadh, Saudi Arabia)2018

Tolerability and discontinuation rates in teriflunomide-treated patients. A real-world clinical experience.

Hind A Alnajashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.